+46.1%
GSK vs SOXQ
+232.9%
-186.8%
-28.5%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SOXQ | Excess | Alpha |
|---|---|---|---|---|
| 1D | 0.0% | +1.8% | -1.8% | 0.0% |
| 7D | -3.5% | +0.8% | -4.3% | -3.5% |
| 30D | -3.4% | -4.6% | +1.1% | -3.4% |
| 3M | -8.1% | -10.2% | +2.0% | -8.1% |
| 6M | -11.1% | +49.7% | -60.8% | -13.2% |
| YTD | +0.7% | +67.2% | -66.5% | -2.1% |
| 1Y | +20.1% | +98.0% | -77.9% | +15.9% |
| 3Y | +46.1% | +237.2% | -191.0% | +40.9% |
| All | +46.1% | +232.9% | -186.8% | +40.9% |
Cumulative growth
Daily Returns
Daily percentage return beside SOXQ.
Daily Out/Under-Performance
Portfolio return minus SOXQ return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SOXQ return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SOXQ wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling